Literature DB >> 12798648

Protective efficacy of oral immunization with heat-killed Shigella flexneri 2a in animal model: study of cross protection, immune response and antigenic recognition.

A Mukhopadhaya1, D Mahalanabis, J Khanam, M K Chakrabarti.   

Abstract

Oral immunization of rabbits with four doses of 10(11) heat-killed Shigella flexneri 2a showed 100% protection against challenge with virulent S. flexneri 2a. After orally immunizing Guinea pigs with four doses of heat-killed S. flexneri 2a 100% protection could be shown against ocular challenge with the same virulent S. flexneri 2a strain but this conferred no protection against challenge with Shigella dysenteriae type 1. In enzyme-linked immunosorbent assay (ELISA) and immunoblot experiments both whole cell lysate-envelope (WCL-E) fraction and outer membrane proteins (OMPs) were recognized by the antisera. Though protective mechanism in shigellosis is not established with certainty, outer membrane proteins (specially 38, 34, 23 and 20kDa proteins) may be the major antigens in the induction of protective immune responses as indicated by this observation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12798648     DOI: 10.1016/s0264-410x(03)00111-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Development and preclinical evaluation of a trivalent, formalin-inactivated Shigella whole-cell vaccine.

Authors:  R W Kaminski; M Wu; K R Turbyfill; K Clarkson; B Tai; A L Bourgeois; L L Van De Verg; R I Walker; E V Oaks
Journal:  Clin Vaccine Immunol       Date:  2014-01-08

2.  Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.

Authors:  BreOnna C DeLaine; Tao Wu; Christen L Grassel; Avital Shimanovich; Marcela F Pasetti; Myron M Levine; Eileen M Barry
Journal:  Pathog Dis       Date:  2016-04-21       Impact factor: 3.166

3.  Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model.

Authors:  Debasis Pore; Nibedita Mahata; Amit Pal; Manoj K Chakrabarti
Journal:  PLoS One       Date:  2011-07-26       Impact factor: 3.240

4.  Finding Potential Therapeutic Targets against Shigella flexneri through Proteome Exploration.

Authors:  Mohammad Uzzal Hossain; Md Arif Khan; Abu Hashem; Md Monirul Islam; Mohammad Neaz Morshed; Chaman Ara Keya; Md Salimullah
Journal:  Front Microbiol       Date:  2016-11-22       Impact factor: 5.640

5.  Outer membrane proteins analysis of Shigella sonnei and evaluation of their antigenicity in Shigella infected individuals.

Authors:  Hemavathy Harikrishnan; Kirnpal Kaur Banga Singh; Asma Ismail
Journal:  PLoS One       Date:  2017-08-28       Impact factor: 3.240

6.  EpiMix Based Novel Vaccine Candidate for Shigella: Evidence of Prophylactic Immunity in Balb/c Mice.

Authors:  Harish Padh; Bhrugu Yagnik; Drashya Sharma; Priti Desai
Journal:  Int J Pept Res Ther       Date:  2021-01-30       Impact factor: 1.931

7.  Shigella flexneri 3a outer membrane protein C epitope is recognized by human umbilical cord sera and associated with protective activity.

Authors:  Anna Jarząb; Danuta Witkowska; Edmund Ziomek; Anna Dąbrowska; Zbigniew Szewczuk; Andrzej Gamian
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.